Tocilizumab Reduces Hypercoagulation in COVID-19 – Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag- ImmCovA) Clinical Trial

Lou M. Almskog; Anna Sjöström; Jonas Sundén-Cullberg; Apostolos Taxiarchis; Anna Ågren; Sara Freyland; Madeleine Börjesson; Agneta Wikman; Carl Magnus Wahlgren; Michael Wanecek; Jan van der Linden; Jovan Antovic; Jon Lampa; Maria Magnusson

doi:10.1101/2024.05.31.24308108

Tocilizumab Reduces Hypercoagulation in COVID-19 – Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag- ImmCovA) Clinical Trial

View ORCID ProfileLou M. Almskog, Anna Sjöström, Jonas Sundén-Cullberg, Apostolos Taxiarchis, Anna Ågren, Sara Freyland, Madeleine Börjesson, Agneta Wikman, Carl Magnus Wahlgren, Michael Wanecek, Jan van der Linden, Jovan Antovic, Jon Lampa, Maria Magnusson

doi: https://doi.org/10.1101/2024.05.31.24308108

Lou M. Almskog

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

2Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Lou M. Almskog
For correspondence: lou.mandelman.almskog{at}ki.se

Anna Sjöström

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

3Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jonas Sundén-Cullberg

4Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

5Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institute, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Apostolos Taxiarchis

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

3Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Anna Ågren

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

6Department of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden

7Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sara Freyland

8Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Madeleine Börjesson

2Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Agneta Wikman

9Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden

10Department of Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carl Magnus Wahlgren

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

11Department of Vascular Surgery, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Wanecek

12Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

13Intensive Care Unit, Capio St Göran’s Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jan van der Linden

12Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jovan Antovic

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

3Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jon Lampa

14Rheumatology Division, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maria Magnusson

1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

7Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden

15Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Article usage

Article usage: June 2024 to June 2025

	Abstract	Full	Pdf
Jun 2024	439	20	72
Jul 2024	135	11	37
Aug 2024	65	6	18
Sep 2024	57	2	12
Oct 2024	42	16	20
Nov 2024	27	0	8
Dec 2024	14	0	19
Jan 2025	54	6	25
Feb 2025	16	19	5
Mar 2025	36	38	13
Apr 2025	29	3	18
May 2025	39	6	14
Jun 2025	5	2	4

View the discussion thread.

PreviousNext

Posted June 10, 2024.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Tocilizumab Reduces Hypercoagulation in COVID-19 – Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag- ImmCovA) Clinical Trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Tocilizumab Reduces Hypercoagulation in COVID-19 – Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag- ImmCovA) Clinical Trial

Lou M. Almskog, Anna Sjöström, Jonas Sundén-Cullberg, Apostolos Taxiarchis, Anna Ågren, Sara Freyland, Madeleine Börjesson, Agneta Wikman, Carl Magnus Wahlgren, Michael Wanecek, Jan van der Linden, Jovan Antovic, Jon Lampa, Maria Magnusson

medRxiv 2024.05.31.24308108; doi: https://doi.org/10.1101/2024.05.31.24308108

Share This Article:

Citation Tools

Tocilizumab Reduces Hypercoagulation in COVID-19 – Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag- ImmCovA) Clinical Trial

medRxiv 2024.05.31.24308108; doi: https://doi.org/10.1101/2024.05.31.24308108

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Hematology

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)